DrKamrava (@kamravamd) 's Twitter Profile
DrKamrava

@kamravamd

Radiation oncologist, brachytherapist, views are my own

ID: 1108941295320334341

calendar_today22-03-2019 03:59:42

787 Tweet

1,1K Takipçi

1,1K Takip Edilen

Adam B. Weiner, MD (@adam_weiner535) 's Twitter Profile Photo

🚨Exercise after #cancer diagnosis🚨 🏋️‍♀️🏋️‍♂️Ask any of my patients with cancer & you'll hear I always encourage fitness ✍️This new work in JNCI shows exercise after a new cancer diagnosis is associated with longer survival 👉This was true for patients with many GU cancers

🚨Exercise after #cancer diagnosis🚨

🏋️‍♀️🏋️‍♂️Ask any of my patients with cancer & you'll hear I always encourage fitness

✍️This new work in <a href="/JNCI_Now/">JNCI</a> shows exercise after a new cancer diagnosis is associated with longer survival

👉This was true for patients with many GU cancers
DrKamrava (@kamravamd) 's Twitter Profile Photo

Implantable rectal spacers (IRS) in prostate cancer radiotherapy: a systematic review - Practical Radiation Oncology practicalradonc.org/article/S1879-… Lots of options in this "space" pros/cons to each I think helpful if rad onc involved in choosing which to use and performing these

The GOG Foundation Inc. (@gog) 's Twitter Profile Photo

To view GOG’s guide to Gynecologic Oncology at ASCO’s abstracts, posters and GYN Clinical trials, go to ow.ly/fNUC50VY1YH #GOGF #GOGPartners #GynecologicOncology #ASCO25 #NationalCancerResearchMonth #RealHopeIs

To view GOG’s guide to Gynecologic Oncology at ASCO’s abstracts, posters and GYN Clinical trials, go to ow.ly/fNUC50VY1YH #GOGF #GOGPartners #GynecologicOncology #ASCO25 #NationalCancerResearchMonth #RealHopeIs
American Brachy (@americanbrachy) 's Twitter Profile Photo

Gleason Grade 9 #prostatecancer is aggressive. When detected with PSA screening before it spreads outside the #prostate, it is a curable #cancer. #Brachytherapy, a highly focused radiation, is a critical component of the treatment. We can help. You're not alone in this journey.

Gleason Grade 9 #prostatecancer is aggressive. When detected with PSA screening before it spreads outside the #prostate, it is a curable #cancer.  #Brachytherapy, a highly focused radiation, is a critical component of the treatment. We can help. You're not alone in this journey.
ASTRO (@astro_org) 's Twitter Profile Photo

New in #practicalRO: A Resident’s Guide to Evaluation of Prostate High Dose Rate Brachytherapy Treatment Plans: An American Brachytherapy Society Technical Report. #radonc tinyurl.com/prohathout

New in #practicalRO: A Resident’s Guide to Evaluation of Prostate High Dose Rate Brachytherapy Treatment Plans: An American Brachytherapy Society Technical Report. #radonc tinyurl.com/prohathout
DrKamrava (@kamravamd) 's Twitter Profile Photo

Preoperative tumour size assessment in patients with early-stage cervical cancer: Final results of the SENTIX study - gynecologiconcology-online.net/article/S0090-… Some size discrepancy probably justifies HR-CTV concept with grey zones to make sure we aren't undertreating?

DrKamrava (@kamravamd) 's Twitter Profile Photo

Deep learning-based applicator selection between Syed and T&O in high-dose-rate brachytherapy for locally advanced cervical cancer: a retrospective study doi.org/10.1088/1361-6… via @ioppublishing ML approach for applicator selection We need multi-I data to build better models

Deep learning-based applicator selection between Syed and T&amp;O in high-dose-rate brachytherapy for locally advanced cervical cancer: a retrospective study doi.org/10.1088/1361-6… via @ioppublishing 
ML approach for applicator selection
We need multi-I data to build better models
Jun Gong (@jgong15) 's Twitter Profile Photo

PhII rand Metacure trial of oligo #mCSPC SBRT to all mets + ADT + apa +/- abi ➡️ PSA0 w/T recovery (primary endpt) met with 42% with short ADT + apa and 50% w/short course ADT + apa and combined group with abi #ASCO25 OncoAlert

PhII rand Metacure trial of oligo #mCSPC SBRT to all mets + ADT + apa +/- abi ➡️ PSA0 w/T recovery (primary endpt) met with 42% with short ADT + apa and 50% w/short course ADT + apa and combined group with abi 

#ASCO25
<a href="/OncoAlert/">OncoAlert</a>
Shannon Westin, MD, MPH, FASCO (@shannonwestin) 's Twitter Profile Photo

Bottom line from the #ctDNA analyses in CALLA study in #CervicalCancer (addition of durva to chemoradiation) 👀 Low ctDNA both at baseline and after completion of chemoXRT associated with better survival 🤔 ctDNA status was most significant prognostic factor #ASCO25 #gyncsm

Bottom line from the #ctDNA analyses in CALLA study in #CervicalCancer (addition of durva to chemoradiation)
👀 Low ctDNA both at baseline and after completion of chemoXRT associated with better survival
🤔 ctDNA status was most significant prognostic factor 
#ASCO25 #gyncsm
Aya Mohamed, MSc, MD 🎗 (@dr_oncologista) 's Twitter Profile Photo

Final analysis of the SG of the ΚΕΥΝΟΤΕ A18. Maintaining Beneficial OS with Addition of Pembro to QTRT Treatment for Locally Advanced Cervical Cancer. #ASCO25 OncoAlert

Final analysis of the SG of the ΚΕΥΝΟΤΕ A18.

Maintaining Beneficial OS with Addition of Pembro to QTRT Treatment for Locally Advanced Cervical Cancer. 

#ASCO25 <a href="/OncoAlert/">OncoAlert</a>